Transplantation Flashcards

1
Q

Define the four types of grafting

A
Autograft = transfer of tissue between different sites within the same organism (e.g. skin graft) 
Isograft = transfer between genetically identical individuals, ie. identical twins, also known as syngeneic  
Allograft = transfer between genetically non-identical members of the same species  
Xenograft = transfer between species
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What happens if there is an ABO incompatibility between donor and recipient?

A

Hyperacute rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe HLA class 1

A

o HLA-A and HLA-B (and C)
o All nucleated cells
o Recognised by cytotoxic T-cells (CD8+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe HLA class 2

A

o HLA-DR (also DP, DQ)
o Only antigen-presenting cells (APCs)
o Recognised by T-helper cells (CD4+)
(most important in rejection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are privileged sites?

A

little or no blood/lymph supply, meaning that the recipient immune system is not exposed to donor antigens and no immunological sensitasation or damage response can take place.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the potential complications of transplantation

A
  • Graft rejection
  • Graft versus host disease (GVHD)
  • Infection - due to immunosuppressive therapy or of transfer of infectious agent in graft)
  • Neoplasia - Lymphoma, Skin tumours
  • Drug side effects
  • Recurrence of original disease
  • Ethical, surgical problems etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What measures are taken to prevent graft rejection?

A
  • ABO matching & detection of pre-sensitisation to donor antigens
  • Close tissue matching (Class I & II HLA - especially at HLA-A, HLA-B & HLA-DR loci)
  • Prophylactic immunosuppressive therapy
  • (Humanised or ‘silenced’ xenografts’)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the cause and timescale of hyperacute rejection

A

Minutes

Caused by Pre-formed antibody against donor HLA or ABO antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the cause and timescale of accelerated rejection

A

2 - 5 days

Caused by Pre-sensitised T-cells (to donor antigens)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the cause and timescale of acute rejection

A

7 - 21 days

Caused by Newly-sensitised T-cells (to donor antigens)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the cause and timescale of chronic rejection

A

Months - years

Multifactoral aetiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is graft versus host disease?

A

Predominantly a complication of bone marrow transplant, where donor immune cells attack the recipient’s tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which tissues are most commonly damaged in GVHD?

A

Skin
Gut
Liver
Immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What circumstances must be present for GVHD to occur?

A
  • The presence of functioning immunocompetent donor T-cells in the graft
  • Defective immunity (particularly T-cell immunity) in the recipient  the recipient is unable to mount an immune response sufficient to eliminate the transplanted cells
  • HLA differences between donor and recipient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the main challenge with xenografts?

A

Humans have naturally acquired IgM class antibodies against pig endothelial galactose antigens, therefore xenografts must be modified to prevent a hyper-acute rejection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the main treatment options for autoimmune diseases?

A
  • Immunosuppressive therapy
  • Anti-inflammatory therapy
  • Plasmapheresis
  • Stem Cell/Bone Marrow Transplant
  • Replacement of lost physiological factor
  • Organ/tissue/mechanical graft
17
Q

Describe the measures taken to prevent GVHD

A
  • Very close tissue matching

* Deplete donor marrow of T-cells in vitro prior to grafting